Skip to main navigation Skip to search Skip to main content

Combined sentinel lymph-node mapping and bone-marrow micrometastatic analysis for improved staging in breast cancer

  • N. Relihan
  • , G. McGreal
  • , J. Kelly
  • , D. Ryan
  • , G. C. O'Sullivan
  • , H. P. Redmond

Research output: Contribution to journalArticlepeer-review

Abstract

In a prospective study of 29 patients with clinically node-negative breast cancer, sampling of rib marrow was superior to sampling of iliac-crest marrow for detection of micrometastases. Combination of marrow micrometastatic analysis with sentinel lymph-node mapping may improve accuracy of staging in breast cancer.

Original languageEnglish
Pages (from-to)129-130
Number of pages2
JournalThe Lancet
Volume354
Issue number9173
DOIs
Publication statusPublished - 10 Jul 1999

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Combined sentinel lymph-node mapping and bone-marrow micrometastatic analysis for improved staging in breast cancer'. Together they form a unique fingerprint.

Cite this